EP2815752
LYFJASAMSETNING TIL INNTÖKU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.2.2013EP published:
20.5.2020EP application number:
13749905.9
EP translation filed:
24.6.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
13.2.2033Expiry date:
13.2.2027Next due date:
28.2.2027
Title:
ORAL PHARMACEUTICAL COMPOSITION
Timeline
Today
14.2.2013EP application
20.5.2020EP Publication
24.6.2020Translation submitted
15.8.2020Registration published
13.2.2027Expires
Owner
Name:
Taiho Pharmaceutical Co., Ltd.Address:
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, JP
Inventor
Name:
OHNISHI, YoshitoAddress:
Tokushima-shi Tokushima 771-0194, JP
Name:
OGATA, TetsuoAddress:
Tokushima-shi Tokushima 771-0194, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2012031144Date:
15.2.2012Country:
JP
Classification
Categories:
A61K 31/513, A61K 31/7072, A61K 9/00, A61K 9/20, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 12.1.2021
Expires: 13.2.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.1.2022
Expires: 13.2.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.1.2023
Expires: 13.2.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.1.2023
Expires: 13.2.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.1.2024
Expires: 13.2.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 16.1.2025
Expires: 13.2.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.2.2026
Expires: 13.2.2027
Payer: Árnason Faktor ehf.